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Background: Smoking is associated with endothelial dysfunction and impaired fibrinolytic status. Omega-3 fatty acids can modify cardiovascular 
risk factors. In the present study we assessed the hypothesis that omega-3 fatty acids can improve endothelial function, arterial stiffness and 
fibrinolytic profile in healthy smokers.
Methods: We studied the effect of a 12 weeks oral treatment with 2gr/day of omega-3 fatty acids in 16 healthy smokers (aged 27.8±2.94y) on 
two occasions (day 0: baseline and day 84). The study was carried out on two separate arms, one with omega-3 fatty acids (2 gr/day) and one 
with placebo, according to a randomized, placebo-controlled, double-blind, cross-over design. Measurements were carried out before (pSm) and 
immediately after (Sm0) cigarette smoking. Endothelial function was evaluated by flow-mediated dilation (FMD) of the brachial artery. Carotid-
femoral pulse wave velocity (PWV) was measured as an index of aortic stiffness and augmentation index (AIx) as a measure of arterial wave 
reflections. Circulating levels of plasminogen activator inhibitor type 1 (PAI-1) were measured by ELISA.
Results: At baseline measurements, compared to pSm, cigarette smoking decreased FMD values (7.26±2.47 % vs 5.53±2.56 %, p<0.005) 
and moreover caused an increase in AIx (0.81±12.58 % vs 5.54±9.84 %, p<0.005) and PWV (5.90±0.62 m/sec vs 6.28±0.73 m/sec, p<0.001). 
Treatment with omega-3 fatty acids improved pSm values of: FMD (7.22±2.54 % vs 10.67±6.32 %, p<0.05), PWV (5.90±0.62 m/sec vs 5.36±0.83 
m/sec, p<0.05) and AIx (0.81±12.58 % vs -3.58±13.22 %, p<0.001), while there was no significant difference with placebo administration. In 
addition, compared with placebo, treatment with omega-3 fatty acids, blunted the acute smoking-induced increase in PWV (0.408±0.42 m/sec vs 
0.103±0.49 m/sec, p<0.05). Finally, pSm levels of PAI-1 were increased after omega-3 fatty acids treatment compared to baseline measurements 
(23.37±16.39 ng/ml vs 9.82±7.245 ng/ml, p<0.01).
Conclusions: Short-term treatment with omega-3 fatty acids improves arterial function and fibrinolytic process in healthy smokers.
